Koninklijke DSM Share Price Euronext Amsterdam
Equities
DSM
NL0000009827
Consumer Goods Conglomerates
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
05-07 | Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI |
05-07 | Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 | CI |
Sales 2024 * | 12.63B 13.67B 1,086B | Sales 2025 * | 13.3B 14.39B 1,143B | Capitalization | 27.96B 30.24B 2,403B |
---|---|---|---|---|---|
Net income 2024 * | 452M 489M 38.84B | Net income 2025 * | 781M 845M 67.11B | EV / Sales 2024 * | 2.44 x |
Net Debt 2024 * | 2.87B 3.1B 246B | Net Debt 2025 * | 2.61B 2.83B 225B | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
61.8
x | P/E ratio 2025 * |
35.7
x | Employees | 28,685 |
Yield 2024 * |
2.39% | Yield 2025 * |
2.35% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/12/89 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 31/08/23 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 31/01/23 | |
Thomas Leysen
CHM | Chairman | 63 | 31/01/23 |
Director/Board Member | 62 | 31/01/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 304 M€ | +16.38% | ||
1.13% | 17 M€ | +7.04% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.12% | 889B | |
0.00% | 239B | |
+25.36% | 175B | |
+42.72% | 84.8B | |
-4.79% | 74.69B | |
-8.45% | 55.13B | |
-26.81% | 37.89B | |
+40.60% | 36.77B | |
+62.18% | 27.71B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock